Partner Adam Polk has been appointed to serve on the Executive Committee in the In re: Allergan BIOCELL Textured Breast Implant Products Liability Litigation.
The lawsuit follows a worldwide recall of BIOCELL products following reports that Allergan’s BIOCELL implants may cause BIA-ALCL, a cancer of the immune system. According to the FDA, the risk of developing BIA-ALCL from Allergan BIOCELL textured implants is about six times greater than from textured implants manufactured by other American companies. Allergan allegedly stated that BIOCELL implants would no longer be sold or distributed in any market, but has not offered to cover medical costs for breast implant revisions—i.e., surgical replacements for the dangerous implants.
Access a copy of the leadership order here, entered on February 25, 2020 by U.S. District Judge Brian R. Martinotti.
Follow us on Instagram and Twitter @GirardSharp for case-related updates.
